BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Trevi Therapeutics 



New Haven  Connecticut    U.S.A.
Phone: 203-304-2499 Fax: 203-304-2434


SEARCH JOBS




Industry
Biotechnology






 Company News
Trevi Therapeutics Selected To Exhibit Poster At 2014 Annual Meeting of the American College of Clinical Pharmacology 9/9/2014 11:35:50 AM
Trevi Therapeutics Announces The Issuance Of Two Patents Covering The Oral Sustained Release Formulation Of Nalbuphine ER 8/14/2014 8:05:09 AM
Trevi Therapeutics Announces Initiation Of A Pivotal Study Of Nalbuphine ER In Uremic Pruritus 7/14/2014 7:09:52 AM
Clinical Stage Biotech Trevi Therapeutics Brings In $25 Million Series B Financing 6/4/2014 6:40:51 AM
Trevi Therapeuitcs Exhibits Poster At 2014 Annual Meeting Of The Society For Investigative Dermatology 5/9/2014 7:49:57 AM
Trevi Therapeuitcs Presents Data at the 7th World Congress on Itch 9/25/2013 6:37:47 AM
Trevi Therapeuitcs Commences Clinical Study of Nalbuphine ER 5/6/2013 10:18:46 AM
Trevi Therapeuitcs Raises $10 Million Series A 12/18/2012 7:45:51 AM